APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gabapentin Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gabapentin Drug Market Outlook and Growth Opportunities 2026

20 December 2025218 pages

Choose your research edition.

Industry ResearchGabapentin Drug Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Gabapentin Drug Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Gabapentin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gabapentin Drug Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Gabapentin Drug Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Gabapentin Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gabapentin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gabapentin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gabapentin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gabapentin Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gabapentin Drug market include Teva, Sun Pharmaceutical, Mylan, Pfizer, Zydus Pharmaceuticals, Tris Pharma, Taro, Sciegen Pharmaceuticals and Marksans Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gabapentin Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gabapentin Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gabapentin Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gabapentin Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Gabapentin Drug Segment by Company

Teva

Sun Pharmaceutical

Mylan

Pfizer

Zydus Pharmaceuticals

Tris Pharma

Taro

Sciegen Pharmaceuticals

Marksans Pharma

Lupin Limited

Jiangsu Hengrui Medicine

InvaGen Pharmaceuticals

Hi-Tech Pharmaceuticals

Glenmark

Epic Pharma

Depomed

CSPC Ouyi Pharmaceutical

Aurobindo Pharma

Apotex

Amneal Pharmaceuticals

Alkem Laboratories

ACI HealthCare Limited

Acella Pharmaceuticals

Gabapentin Drug Segment by Type

Capsule

Oral Solution

Tablet

Gabapentin Drug Segment by Application

Postherpetic Neuralgia in Adults

Partial Onset Seizures

Others

Gabapentin Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Gabapentin Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gabapentin Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gabapentin Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Gabapentin Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gabapentin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gabapentin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gabapentin Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gabapentin Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gabapentin Drug industry.

Chapter 3: Detailed analysis of Gabapentin Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gabapentin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gabapentin Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gabapentin Drug Industry Trends Table 2. Gabapentin Drug Industry Drivers Table 3. Gabapentin Drug Industry Opportunities and Challenges Table 4. Gabapentin Drug Industry Restraints Table 5. Global Gabapentin Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gabapentin Drug Revenue Share by Company (2021-2026) Table 7. Global Gabapentin Drug Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Gabapentin Drug Sales Volume Share by Company (2021-2026) Table 9. Global Gabapentin Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Gabapentin Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gabapentin Drug Key Company Manufacturing Base & Headquarters Table 12. Global Gabapentin Drug Company, Product Type & Application Table 13. Global Gabapentin Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gabapentin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsule Table 18. Significant Companies of Oral Solution Table 19. Significant Companies of Tablet Table 20. Global Gabapentin Drug Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Gabapentin Drug Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Gabapentin Drug Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Gabapentin Drug Sales Volume Share by Type (2021-2026) Table 24. Global Gabapentin Drug Sales Volume Share by Type (2027-2032) Table 25. Global Gabapentin Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gabapentin Drug Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Gabapentin Drug Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Gabapentin Drug Sales Value Share by Type (2021-2026) Table 29. Global Gabapentin Drug Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Postherpetic Neuralgia in Adults Table 31. Significant Companies of Partial Onset Seizures Table 32. Significant Companies of Others Table 33. Global Gabapentin Drug Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Gabapentin Drug Sales Volume by Application (2021-2026) & (W Units) Table 35. Global Gabapentin Drug Sales Volume by Application (2027-2032) & (W Units) Table 36. Global Gabapentin Drug Sales Volume Share by Application (2021-2026) Table 37. Global Gabapentin Drug Sales Volume Share by Application (2027-2032) Table 38. Global Gabapentin Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Gabapentin Drug Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Gabapentin Drug Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Gabapentin Drug Sales Value Share by Application (2021-2026) Table 42. Global Gabapentin Drug Sales Value Share by Application (2027-2032) Table 43. Global Gabapentin Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Gabapentin Drug Sales by Region (2021-2026) & (W Units) Table 45. Global Gabapentin Drug Sales Market Share by Region (2021-2026) Table 46. Global Gabapentin Drug Sales by Region (2027-2032) & (W Units) Table 47. Global Gabapentin Drug Sales Market Share by Region (2027-2032) Table 48. Global Gabapentin Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Gabapentin Drug Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Gabapentin Drug Sales Value Share by Region (2021-2026) Table 51. Global Gabapentin Drug Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Gabapentin Drug Sales Value Share by Region (2027-2032) Table 53. Global Gabapentin Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Gabapentin Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Gabapentin Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Global Gabapentin Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 58. Global Gabapentin Drug Sales Market Share by Country (2021-2026) Table 59. Global Gabapentin Drug Sales by Country (2027-2032) & (W Units) Table 60. Global Gabapentin Drug Sales Market Share by Country (2027-2032) Table 61. Global Gabapentin Drug Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Gabapentin Drug Sales Value Market Share by Country (2021-2026) Table 63. Global Gabapentin Drug Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Gabapentin Drug Sales Value Market Share by Country (2027-2032) Table 65. Teva Company Information Table 66. Teva Business Overview Table 67. Teva Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Teva Gabapentin Drug Product Portfolio Table 69. Teva Recent Development Table 70. Sun Pharmaceutical Company Information Table 71. Sun Pharmaceutical Business Overview Table 72. Sun Pharmaceutical Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Sun Pharmaceutical Gabapentin Drug Product Portfolio Table 74. Sun Pharmaceutical Recent Development Table 75. Mylan Company Information Table 76. Mylan Business Overview Table 77. Mylan Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Mylan Gabapentin Drug Product Portfolio Table 79. Mylan Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Pfizer Gabapentin Drug Product Portfolio Table 84. Pfizer Recent Development Table 85. Zydus Pharmaceuticals Company Information Table 86. Zydus Pharmaceuticals Business Overview Table 87. Zydus Pharmaceuticals Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Zydus Pharmaceuticals Gabapentin Drug Product Portfolio Table 89. Zydus Pharmaceuticals Recent Development Table 90. Tris Pharma Company Information Table 91. Tris Pharma Business Overview Table 92. Tris Pharma Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Tris Pharma Gabapentin Drug Product Portfolio Table 94. Tris Pharma Recent Development Table 95. Taro Company Information Table 96. Taro Business Overview Table 97. Taro Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Taro Gabapentin Drug Product Portfolio Table 99. Taro Recent Development Table 100. Sciegen Pharmaceuticals Company Information Table 101. Sciegen Pharmaceuticals Business Overview Table 102. Sciegen Pharmaceuticals Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio Table 104. Sciegen Pharmaceuticals Recent Development Table 105. Marksans Pharma Company Information Table 106. Marksans Pharma Business Overview Table 107. Marksans Pharma Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Marksans Pharma Gabapentin Drug Product Portfolio Table 109. Marksans Pharma Recent Development Table 110. Lupin Limited Company Information Table 111. Lupin Limited Business Overview Table 112. Lupin Limited Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Lupin Limited Gabapentin Drug Product Portfolio Table 114. Lupin Limited Recent Development Table 115. Jiangsu Hengrui Medicine Company Information Table 116. Jiangsu Hengrui Medicine Business Overview Table 117. Jiangsu Hengrui Medicine Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio Table 119. Jiangsu Hengrui Medicine Recent Development Table 120. InvaGen Pharmaceuticals Company Information Table 121. InvaGen Pharmaceuticals Business Overview Table 122. InvaGen Pharmaceuticals Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio Table 124. InvaGen Pharmaceuticals Recent Development Table 125. Hi-Tech Pharmaceuticals Company Information Table 126. Hi-Tech Pharmaceuticals Business Overview Table 127. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio Table 129. Hi-Tech Pharmaceuticals Recent Development Table 130. Glenmark Company Information Table 131. Glenmark Business Overview Table 132. Glenmark Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Glenmark Gabapentin Drug Product Portfolio Table 134. Glenmark Recent Development Table 135. Epic Pharma Company Information Table 136. Epic Pharma Business Overview Table 137. Epic Pharma Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Epic Pharma Gabapentin Drug Product Portfolio Table 139. Epic Pharma Recent Development Table 140. Depomed Company Information Table 141. Depomed Business Overview Table 142. Depomed Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Depomed Gabapentin Drug Product Portfolio Table 144. Depomed Recent Development Table 145. CSPC Ouyi Pharmaceutical Company Information Table 146. CSPC Ouyi Pharmaceutical Business Overview Table 147. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio Table 149. CSPC Ouyi Pharmaceutical Recent Development Table 150. Aurobindo Pharma Company Information Table 151. Aurobindo Pharma Business Overview Table 152. Aurobindo Pharma Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Aurobindo Pharma Gabapentin Drug Product Portfolio Table 154. Aurobindo Pharma Recent Development Table 155. Apotex Company Information Table 156. Apotex Business Overview Table 157. Apotex Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Apotex Gabapentin Drug Product Portfolio Table 159. Apotex Recent Development Table 160. Amneal Pharmaceuticals Company Information Table 161. Amneal Pharmaceuticals Business Overview Table 162. Amneal Pharmaceuticals Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Amneal Pharmaceuticals Gabapentin Drug Product Portfolio Table 164. Amneal Pharmaceuticals Recent Development Table 165. Alkem Laboratories Company Information Table 166. Alkem Laboratories Business Overview Table 167. Alkem Laboratories Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Alkem Laboratories Gabapentin Drug Product Portfolio Table 169. Alkem Laboratories Recent Development Table 170. ACI HealthCare Limited Company Information Table 171. ACI HealthCare Limited Business Overview Table 172. ACI HealthCare Limited Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. ACI HealthCare Limited Gabapentin Drug Product Portfolio Table 174. ACI HealthCare Limited Recent Development Table 175. Acella Pharmaceuticals Company Information Table 176. Acella Pharmaceuticals Business Overview Table 177. Acella Pharmaceuticals Gabapentin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 178. Acella Pharmaceuticals Gabapentin Drug Product Portfolio Table 179. Acella Pharmaceuticals Recent Development Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. Gabapentin Drug Distributors List Table 183. Gabapentin Drug Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. Gabapentin Drug Product Image Figure 2. Global Gabapentin Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gabapentin Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gabapentin Drug Sales (2021-2032) & (W Units) Figure 5. Global Gabapentin Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Gabapentin Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsule Image Figure 10. Oral Solution Image Figure 11. Tablet Image Figure 12. Global Gabapentin Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Gabapentin Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Gabapentin Drug Sales Volume Share by Type (2021-2032) Figure 15. Global Gabapentin Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Gabapentin Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Gabapentin Drug Sales Value Share by Type (2021-2032) Figure 18. Postherpetic Neuralgia in Adults Image Figure 19. Partial Onset Seizures Image Figure 20. Others Image Figure 21. Global Gabapentin Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Gabapentin Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Gabapentin Drug Sales Volume Share by Application (2021-2032) Figure 24. Global Gabapentin Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Gabapentin Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Gabapentin Drug Sales Value Share by Application (2021-2032) Figure 27. Global Gabapentin Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 28. Global Gabapentin Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Gabapentin Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Gabapentin Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Gabapentin Drug Sales Value (2021-2032) & (US$ Million) Figure 32. North America Gabapentin Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Gabapentin Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Gabapentin Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Gabapentin Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Gabapentin Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Gabapentin Drug Sales Value (2021-2032) & (US$ Million) Figure 38. South America Gabapentin Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Gabapentin Drug Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Gabapentin Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Gabapentin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Gabapentin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Gabapentin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Gabapentin Drug Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Gabapentin Drug Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Oral Solution
  • Tablet
Applications
  • Postherpetic Neuralgia in Adults
  • Partial Onset Seizures
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Mylan
  • Pfizer
  • Zydus Pharmaceuticals
  • Tris Pharma
  • Taro
  • Sciegen Pharmaceuticals
  • Marksans Pharma
  • Lupin Limited
  • Jiangsu Hengrui Medicine
  • InvaGen Pharmaceuticals
  • Hi-Tech Pharmaceuticals
  • Glenmark
  • Epic Pharma
  • Depomed
  • CSPC Ouyi Pharmaceutical
  • Aurobindo Pharma
  • Apotex
  • Amneal Pharmaceuticals
  • Alkem Laboratories
  • ACI HealthCare Limited
  • Acella Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gabapentin Drug Sales Value (2021-2032)
  4. 1.2.2 Global Gabapentin Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Gabapentin Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gabapentin Drug Market Dynamics
  1. 2.1 Gabapentin Drug Industry Trends
  2. 2.2 Gabapentin Drug Industry Drivers
  3. 2.3 Gabapentin Drug Industry Opportunities and Challenges
  4. 2.4 Gabapentin Drug Industry Restraints
3 Gabapentin Drug Market by Company
  1. 3.1 Global Gabapentin Drug Company Revenue Ranking in 2025
  2. 3.2 Global Gabapentin Drug Revenue by Company (2021-2026)
  3. 3.3 Global Gabapentin Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Gabapentin Drug Average Price by Company (2021-2026)
  5. 3.5 Global Gabapentin Drug Company Ranking (2024-2026)
  6. 3.6 Global Gabapentin Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Gabapentin Drug Company Product Type and Application
  8. 3.8 Global Gabapentin Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gabapentin Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gabapentin Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gabapentin Drug Market by Type
  1. 4.1 Gabapentin Drug Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Oral Solution
  4. 4.1.3 Tablet
  5. 4.2 Global Gabapentin Drug Sales Volume by Type
  6. 4.2.1 Global Gabapentin Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Gabapentin Drug Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Gabapentin Drug Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Gabapentin Drug Sales Value by Type
  10. 4.3.1 Global Gabapentin Drug Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Gabapentin Drug Sales Value by Type (2021-2032)
  12. 4.3.3 Global Gabapentin Drug Sales Value Share by Type (2021-2032)
5 Gabapentin Drug Market by Application
  1. 5.1 Gabapentin Drug Application Introduction
  2. 5.1.1 Postherpetic Neuralgia in Adults
  3. 5.1.2 Partial Onset Seizures
  4. 5.1.3 Others
  5. 5.2 Global Gabapentin Drug Sales Volume by Application
  6. 5.2.1 Global Gabapentin Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gabapentin Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gabapentin Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gabapentin Drug Sales Value by Application
  10. 5.3.1 Global Gabapentin Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gabapentin Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gabapentin Drug Sales Value Share by Application (2021-2032)
6 Gabapentin Drug Regional Sales and Value Analysis
  1. 6.1 Global Gabapentin Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gabapentin Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Gabapentin Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Gabapentin Drug Sales by Region (2027-2032)
  5. 6.3 Global Gabapentin Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gabapentin Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gabapentin Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gabapentin Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Gabapentin Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gabapentin Drug Sales Value (2021-2032)
  12. 6.6.2 North America Gabapentin Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gabapentin Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Gabapentin Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gabapentin Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gabapentin Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gabapentin Drug Sales Value (2021-2032)
  21. 6.9.2 South America Gabapentin Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gabapentin Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gabapentin Drug Sales Value Share by Country, 2025 VS 2032
7 Gabapentin Drug Country-level Sales and Value Analysis
  1. 7.1 Global Gabapentin Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gabapentin Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gabapentin Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Gabapentin Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Gabapentin Drug Sales by Country (2027-2032)
  6. 7.4 Global Gabapentin Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gabapentin Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gabapentin Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gabapentin Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gabapentin Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gabapentin Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gabapentin Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gabapentin Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gabapentin Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gabapentin Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gabapentin Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gabapentin Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gabapentin Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gabapentin Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gabapentin Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gabapentin Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gabapentin Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gabapentin Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gabapentin Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gabapentin Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gabapentin Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gabapentin Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gabapentin Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gabapentin Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gabapentin Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gabapentin Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gabapentin Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gabapentin Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gabapentin Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gabapentin Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gabapentin Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gabapentin Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gabapentin Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Gabapentin Drug Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Gabapentin Drug Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Gabapentin Drug Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Gabapentin Drug Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Zydus Pharmaceuticals
  26. 8.5.1 Zydus Pharmaceuticals Company Information
  27. 8.5.2 Zydus Pharmaceuticals Business Overview
  28. 8.5.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zydus Pharmaceuticals Gabapentin Drug Product Portfolio
  30. 8.5.5 Zydus Pharmaceuticals Recent Developments
  31. 8.6 Tris Pharma
  32. 8.6.1 Tris Pharma Company Information
  33. 8.6.2 Tris Pharma Business Overview
  34. 8.6.3 Tris Pharma Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tris Pharma Gabapentin Drug Product Portfolio
  36. 8.6.5 Tris Pharma Recent Developments
  37. 8.7 Taro
  38. 8.7.1 Taro Company Information
  39. 8.7.2 Taro Business Overview
  40. 8.7.3 Taro Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Taro Gabapentin Drug Product Portfolio
  42. 8.7.5 Taro Recent Developments
  43. 8.8 Sciegen Pharmaceuticals
  44. 8.8.1 Sciegen Pharmaceuticals Company Information
  45. 8.8.2 Sciegen Pharmaceuticals Business Overview
  46. 8.8.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio
  48. 8.8.5 Sciegen Pharmaceuticals Recent Developments
  49. 8.9 Marksans Pharma
  50. 8.9.1 Marksans Pharma Company Information
  51. 8.9.2 Marksans Pharma Business Overview
  52. 8.9.3 Marksans Pharma Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Marksans Pharma Gabapentin Drug Product Portfolio
  54. 8.9.5 Marksans Pharma Recent Developments
  55. 8.10 Lupin Limited
  56. 8.10.1 Lupin Limited Company Information
  57. 8.10.2 Lupin Limited Business Overview
  58. 8.10.3 Lupin Limited Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lupin Limited Gabapentin Drug Product Portfolio
  60. 8.10.5 Lupin Limited Recent Developments
  61. 8.11 Jiangsu Hengrui Medicine
  62. 8.11.1 Jiangsu Hengrui Medicine Company Information
  63. 8.11.2 Jiangsu Hengrui Medicine Business Overview
  64. 8.11.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio
  66. 8.11.5 Jiangsu Hengrui Medicine Recent Developments
  67. 8.12 InvaGen Pharmaceuticals
  68. 8.12.1 InvaGen Pharmaceuticals Company Information
  69. 8.12.2 InvaGen Pharmaceuticals Business Overview
  70. 8.12.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio
  72. 8.12.5 InvaGen Pharmaceuticals Recent Developments
  73. 8.13 Hi-Tech Pharmaceuticals
  74. 8.13.1 Hi-Tech Pharmaceuticals Company Information
  75. 8.13.2 Hi-Tech Pharmaceuticals Business Overview
  76. 8.13.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio
  78. 8.13.5 Hi-Tech Pharmaceuticals Recent Developments
  79. 8.14 Glenmark
  80. 8.14.1 Glenmark Company Information
  81. 8.14.2 Glenmark Business Overview
  82. 8.14.3 Glenmark Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Glenmark Gabapentin Drug Product Portfolio
  84. 8.14.5 Glenmark Recent Developments
  85. 8.15 Epic Pharma
  86. 8.15.1 Epic Pharma Company Information
  87. 8.15.2 Epic Pharma Business Overview
  88. 8.15.3 Epic Pharma Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Epic Pharma Gabapentin Drug Product Portfolio
  90. 8.15.5 Epic Pharma Recent Developments
  91. 8.16 Depomed
  92. 8.16.1 Depomed Company Information
  93. 8.16.2 Depomed Business Overview
  94. 8.16.3 Depomed Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Depomed Gabapentin Drug Product Portfolio
  96. 8.16.5 Depomed Recent Developments
  97. 8.17 CSPC Ouyi Pharmaceutical
  98. 8.17.1 CSPC Ouyi Pharmaceutical Company Information
  99. 8.17.2 CSPC Ouyi Pharmaceutical Business Overview
  100. 8.17.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio
  102. 8.17.5 CSPC Ouyi Pharmaceutical Recent Developments
  103. 8.18 Aurobindo Pharma
  104. 8.18.1 Aurobindo Pharma Company Information
  105. 8.18.2 Aurobindo Pharma Business Overview
  106. 8.18.3 Aurobindo Pharma Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Aurobindo Pharma Gabapentin Drug Product Portfolio
  108. 8.18.5 Aurobindo Pharma Recent Developments
  109. 8.19 Apotex
  110. 8.19.1 Apotex Company Information
  111. 8.19.2 Apotex Business Overview
  112. 8.19.3 Apotex Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Apotex Gabapentin Drug Product Portfolio
  114. 8.19.5 Apotex Recent Developments
  115. 8.20 Amneal Pharmaceuticals
  116. 8.20.1 Amneal Pharmaceuticals Company Information
  117. 8.20.2 Amneal Pharmaceuticals Business Overview
  118. 8.20.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Amneal Pharmaceuticals Gabapentin Drug Product Portfolio
  120. 8.20.5 Amneal Pharmaceuticals Recent Developments
  121. 8.21 Alkem Laboratories
  122. 8.21.1 Alkem Laboratories Company Information
  123. 8.21.2 Alkem Laboratories Business Overview
  124. 8.21.3 Alkem Laboratories Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Alkem Laboratories Gabapentin Drug Product Portfolio
  126. 8.21.5 Alkem Laboratories Recent Developments
  127. 8.22 ACI HealthCare Limited
  128. 8.22.1 ACI HealthCare Limited Company Information
  129. 8.22.2 ACI HealthCare Limited Business Overview
  130. 8.22.3 ACI HealthCare Limited Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 ACI HealthCare Limited Gabapentin Drug Product Portfolio
  132. 8.22.5 ACI HealthCare Limited Recent Developments
  133. 8.23 Acella Pharmaceuticals
  134. 8.23.1 Acella Pharmaceuticals Company Information
  135. 8.23.2 Acella Pharmaceuticals Business Overview
  136. 8.23.3 Acella Pharmaceuticals Gabapentin Drug Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Acella Pharmaceuticals Gabapentin Drug Product Portfolio
  138. 8.23.5 Acella Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gabapentin Drug Value Chain Analysis
  2. 9.1.1 Gabapentin Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gabapentin Drug Sales Mode & Process
  6. 9.2 Gabapentin Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gabapentin Drug Distributors
  9. 9.2.3 Gabapentin Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst